Sartorius Stedim Biotech reports 97,330,405 issued shares, 164,752,145 net voting rights as of Sept. 30, 2026

By Public Technologies
  • Sartorius Stedim Biotech reported 97,330,405 shares outstanding as of Sept. 30, 2026.
  • Theoretical voting rights totaled 164,770,938, including treasury shares.
  • Net voting rights stood at 164,752,145.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sartorius Stedim Biotech SA published the original content used to generate this news brief via EQS News (Ref. ID: fr_reg_2409128_en) on October 01, 2026, and is solely responsible for the information contained therein.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk